Accuray (ARAY) Cash from Financing Activities (2010 - 2026)
Accuray (ARAY) posted quarterly Cash from Financing Activities of $4.1 million for Q1 2026, up 158.0% year-over-year from $1.6 million in Q1 2025, and up 1557.45% quarter-over-quarter from -$282000.0 in Q4 2025.
Accuray (ARAY) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Accuray's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 158.0% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.9 million (up 156.4% YoY), while the FY2025 annual figure was -$4.3 million, down 7.62% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $4.1 million, up from -$282000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $5.8 million in Q4 2024, with the low at -$15.5 million in Q1 2022.
- The 5-year median for Cash from Financing Activities is -$475000.0 (2025), against an average of -$1.1 million.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities sank 336.5% in 2022, then jumped 2343.58% in 2024.
- Accuray's Cash from Financing Activities stood at $4.3 million in 2022, then sank by 106.01% to -$257000.0 in 2023, then surged by 2343.58% to $5.8 million in 2024, then sank by 104.89% to -$282000.0 in 2025, then jumped by 1557.45% to $4.1 million in 2026.
- Business Quant data shows ARAY's Cash from Financing Activities at $4.1 million in Q1 2026, -$282000.0 in Q4 2025, and -$475000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Accuray | 36.52 Mn | -3.18 Mn | 25.29 Mn | 4.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.11 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | -282,000.00 |
| Dec 31, 2025 | -282,000.00 |
| Sep 30, 2025 | -475,000.00 |
| Sep 30, 2025 | -475,000.00 |
| Mar 31, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | -2.17 Mn |
| Sep 30, 2024 | -2.17 Mn |
| Mar 31, 2024 | -3.26 Mn |
| Mar 31, 2024 | -3.26 Mn |
| Dec 31, 2023 | -257,000.00 |
| Dec 31, 2023 | -257,000.00 |
| Sep 30, 2023 | -1.50 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Mar 31, 2023 | -1.59 Mn |
| Mar 31, 2023 | -1.59 Mn |